{
  "BAYA.DE": {
    "city": "Leverkusen",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "GER",
    "industry": "Drug Manufacturers - Major",
    "long_name": "Bayer Aktiengesellschaft",
    "market": "de_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "BAYER ADR /1/4",
    "state": null,
    "summary": "Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. Bayer Aktiengesellschaft has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc. and Forschungszentrum JÃ¼lich GmbH; strategic research partnership with University of Oxford to develop novel gynecological therapies; and research collaboration agreements with Haplogen GmbH and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.",
    "website": "http://www.bayer.com",
    "zipcode": "51368"
  },
  "BAYNN.MX": {
    "city": "Leverkusen",
    "country": "Germany",
    "currency": "MXN",
    "exchange": "MEX",
    "industry": "Drug Manufacturers - Major",
    "long_name": "Bayer Aktiengesellschaft",
    "market": "mx_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "BAYER AG",
    "state": null,
    "summary": "Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. Bayer Aktiengesellschaft has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc. and Forschungszentrum JÃ¼lich GmbH; strategic research partnership with University of Oxford to develop novel gynecological therapies; and research collaboration agreements with Haplogen GmbH and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.",
    "website": "http://www.bayer.com",
    "zipcode": "51368"
  },
  "DPHN.MX": {
    "city": "Northwich",
    "country": "United Kingdom",
    "currency": "MXN",
    "exchange": "MEX",
    "industry": "Drug Manufacturers - Major",
    "long_name": "Dechra Pharmaceuticals PLC",
    "market": "mx_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "DECHRA PHARMACEUTICALS",
    "state": null,
    "summary": "Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians worldwide. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, and critical care products for dogs and cats; water soluble antibiotics, poultry vaccines, and pain management for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies. It also provides pet nutrition products for supporting cats and dogs with various therapeutic conditions, such as allergies, obesity, heart, and kidney diseases. In addition, the company distributes veterinary pharmaceuticals and equipment; offers financial services; markets pet diets; and develops, regulates, manufactures, and markets crop protection. It markets its products through wholesaler and distributor networks. Dechra Pharmaceuticals PLC was incorporated in 1997 and is headquartered in Northwich, the United Kingdom.",
    "website": "http://www.dechra.com",
    "zipcode": "CW9 7UA"
  },
  "LAVI.AT": {
    "city": "Paiania",
    "country": "Greece",
    "currency": "EUR",
    "exchange": "ATH",
    "industry": "Drug Manufacturers - Major",
    "long_name": "Lavipharm S.A.",
    "market": "gr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "LAVIPHARM S.A. (CR)",
    "state": null,
    "summary": "Lavipharm S.A. engages in the research, development, manufacturing, import, marketing, sales, wholesaling, and retailing of pharmaceutical, dermocosmetic, and healthcare products in Greece and internationally. The company offers pharmaceutical products for cardiology, chronic pain and oncology, central nervous system, respiratory system, gastrointestinal system, and urology; over the counter (OTC) drugs, such as antiseptics, and analgesics; gynecological products; and anti-lice treatment drugs. It also provides transdermal drug delivery systems (TDDS) related to pain management, hypertension, angina pectoris, Parkinson disease, asthma, female or male hormone replacement therapy, contraception, nausea, incontinence, etc. In addition, the company's product pipeline includes nicotine TDDS for smoking cessation; TDDS for hypertension; range of OTC products for common cold, oral hygiene, excessive excretion of shawl; food supplements; and anti-ageing products. Lavipharm S.A. was founded in 1911 and is based in Paiania, Greece.",
    "website": "http://www.lavipharm.gr",
    "zipcode": "190 02"
  },
  "SANNV.PA": {
    "city": "Paris",
    "country": "France",
    "currency": "EUR",
    "exchange": "PAR",
    "industry": "Drug Manufacturers - Major",
    "long_name": "Sanofi",
    "market": "fr_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "SANOFI NV21",
    "state": null,
    "summary": "Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. It also has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.",
    "website": "http://www.sanofi.com",
    "zipcode": "75008"
  },
  "SNYN.MX": {
    "city": "Paris",
    "country": "France",
    "currency": "MXN",
    "exchange": "MEX",
    "industry": "Drug Manufacturers - Major",
    "long_name": "Sanofi",
    "market": "mx_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "SANOFI",
    "state": null,
    "summary": "Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. It also has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.",
    "website": "http://www.sanofi.com",
    "zipcode": "75008"
  }
}
